Overview Financials News + Filings Key Docs Charts Transactions Holdings Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags CC transcript Quarterly results
|
TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA)
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
08/10/2023 |
4
| Grant Angus (EVP, Business Development) has filed a Form 4 on TEVA PHARMACEUTICAL INDUSTRIES LTD
Txns:
| Granted 51,652 options to buy
@ $0 |
|
08/09/2023 |
4
| Kalif Eliyahu Sharon (EVP, CFO) has filed a Form 4 on TEVA PHARMACEUTICAL INDUSTRIES LTD
Txns:
| Sold 35,125 shares
@ $9.7335, valued at
$341.9k
|
|
08/07/2023 |
4
| Weiss Amir (Chief Accounting Officer) has filed a Form 4 on TEVA PHARMACEUTICAL INDUSTRIES LTD
Txns:
| Sold 1,981 shares
@ $9.921, valued at
$19.7k
|
|
08/07/2023 |
4
| Vergis Janet S. (Director) has filed a Form 4 on TEVA PHARMACEUTICAL INDUSTRIES LTD
Txns:
| Exercised 15,810 options to buy
@ $0 |
|
08/07/2023 |
4
| Satchi-Fainaro Ronit (Director) has filed a Form 4 on TEVA PHARMACEUTICAL INDUSTRIES LTD
Txns:
| Exercised 15,810 options to buy
@ $0 |
|
08/07/2023 |
4
| Nisen Perry (Director) has filed a Form 4 on TEVA PHARMACEUTICAL INDUSTRIES LTD
Txns:
| Exercised 15,810 options to buy
@ $0 |
|
08/07/2023 |
4
| MIGNONE ROBERTO (Director) has filed a Form 4 on TEVA PHARMACEUTICAL INDUSTRIES LTD
Txns:
| Exercised 15,810 options to buy
@ $0 |
|
08/07/2023 |
4
| LIEBERMAN GERALD M (Director) has filed a Form 4 on TEVA PHARMACEUTICAL INDUSTRIES LTD
Txns:
| Exercised 15,810 options to buy
@ $0 |
|
08/07/2023 |
4
| Elstein Amir (Director) has filed a Form 4 on TEVA PHARMACEUTICAL INDUSTRIES LTD
Txns:
| Exercised 15,810 options to buy
@ $0 |
|
08/07/2023 |
4
| Crane Rosemary A (Director) has filed a Form 4 on TEVA PHARMACEUTICAL INDUSTRIES LTD
Txns:
| Exercised 15,810 options to buy
@ $0 |
|
08/07/2023 |
4
| BARER SOL J (Director) has filed a Form 4 on TEVA PHARMACEUTICAL INDUSTRIES LTD
Txns:
| Exercised 28,162 options to buy
@ $0 |
|
08/03/2023 |
4
| Hughes Eric A (See "Remarks") has filed a Form 4 on TEVA PHARMACEUTICAL INDUSTRIES LTD
Txns:
| Sold 52,742 shares
@ $8.2987, valued at
$437.7k
Exercised 52,742 options to buy
@ $0 |
|
03/08/2023 |
4
| Stark David Matthew (Exec. VP Chief Legal Officer) has filed a Form 4 on TEVA PHARMACEUTICAL INDUSTRIES LTD
Txns:
| Sold 16,491 shares
@ $9.9309, valued at
$163.8k
Sold 49,475 shares
@ $9.4279, valued at
$466.4k
|
|
03/08/2023 |
4
| Drape Eric (Executive VP Global Operations) has filed a Form 4 on TEVA PHARMACEUTICAL INDUSTRIES LTD
Txns:
| Sold 1,566 shares
@ $9.9309, valued at
$15.6k
Sold 4,699 shares
@ $9.4279, valued at
$44.3k
|
|
03/08/2023 |
4
| Dethlefs Sven (EVP, North America Commercial) has filed a Form 4 on TEVA PHARMACEUTICAL INDUSTRIES LTD
Txns:
| Sold 19,355 shares
@ $9.9309, valued at
$192.2k
Sold 58,066 shares
@ $9.4279, valued at
$547.4k
|
|
03/08/2023 |
4
| Daniell Richard (Exec. VP, European Commercial) has filed a Form 4 on TEVA PHARMACEUTICAL INDUSTRIES LTD
Txns:
| Sold 18,002 shares
@ $9.9309, valued at
$178.8k
Sold 54,007 shares
@ $9.4279, valued at
$509.2k
|
|
03/07/2023 |
4
| Weiss Amir (Chief Accounting Officer) has filed a Form 4 on TEVA PHARMACEUTICAL INDUSTRIES LTD
Txns:
| Granted 20,717 options to buy
@ $0 Exercised 2,406 options to buy
@ $0 Exercised 10,676 options to buy
@ $0 Exercised 3,564 options to buy
@ $0 |
|
03/07/2023 |
4
| Stark David Matthew (Exec. VP Chief Legal Officer) has filed a Form 4 on TEVA PHARMACEUTICAL INDUSTRIES LTD
Txns:
| Granted 94,621 options to buy
@ $0 Exercised 13,931 options to buy
@ $0 Exercised 31,836 options to buy
@ $0 Exercised 20,199 options to buy
@ $0 |
|
03/07/2023 |
4
| Shani Eli (EVP,Global Marketing&Portfolio) has filed a Form 4 on TEVA PHARMACEUTICAL INDUSTRIES LTD
Txns:
| Granted 59,760 options to buy
@ $0 Exercised 3,173 options to buy
@ $0 Exercised 20,107 options to buy
@ $0 Exercised 5,896 options to buy
@ $0 |
|
03/07/2023 |
4
| Sabag Mark (EVP, International Markets) has filed a Form 4 on TEVA PHARMACEUTICAL INDUSTRIES LTD
Txns:
| Granted 99,601 options to buy
@ $0 Exercised 15,921 options to buy
@ $0 Exercised 33,512 options to buy
@ $0 Exercised 23,764 options to buy
@ $0 |
|
03/07/2023 |
4
| Kalif Eliyahu Sharon (EVP, CFO) has filed a Form 4 on TEVA PHARMACEUTICAL INDUSTRIES LTD
Txns:
| Granted 199,202 options to buy
@ $0 Exercised 33,512 options to buy
@ $0 Exercised 21,387 options to buy
@ $0 |
|
03/07/2023 |
4
| Inbar Galia (See "Remarks") has filed a Form 4 on TEVA PHARMACEUTICAL INDUSTRIES LTD
Txns:
| Granted 59,760 options to buy
@ $0 Exercised 20,107 options to buy
@ $0 Exercised 5,710 options to buy
@ $0 |
|
03/07/2023 |
4
| Hughes Eric A (See "Remarks") has filed a Form 4 on TEVA PHARMACEUTICAL INDUSTRIES LTD
Txns:
| Granted 99,601 options to buy
@ $0 |
|
03/07/2023 |
4
| Drape Eric (Executive VP Global Operations) has filed a Form 4 on TEVA PHARMACEUTICAL INDUSTRIES LTD
Txns:
| Granted 99,601 options to buy
@ $0 Exercised 11,940 options to buy
@ $0 Exercised 33,512 options to buy
@ $0 Exercised 22,576 options to buy
@ $0 |
|
03/07/2023 |
4
| Dethlefs Sven (EVP, North America Commercial) has filed a Form 4 on TEVA PHARMACEUTICAL INDUSTRIES LTD
Txns:
| Granted 99,601 options to buy
@ $0 Exercised 13,931 options to buy
@ $0 Exercised 38,538 options to buy
@ $0 Exercised 24,952 options to buy
@ $0 |
|
03/07/2023 |
4
| Daniell Richard (Exec. VP, European Commercial) has filed a Form 4 on TEVA PHARMACEUTICAL INDUSTRIES LTD
Txns:
| Granted 249,003 options to buy
@ $0 Exercised 15,921 options to buy
@ $0 Exercised 33,512 options to buy
@ $0 Exercised 22,576 options to buy
@ $0 |
|
03/02/2023 |
4
| Weiss Amir (Chief Accounting Officer) has filed a Form 4 on TEVA PHARMACEUTICAL INDUSTRIES LTD
Txns:
| Exercised 3,219 options to buy
@ $0 |
|
03/02/2023 |
4
| Stark David Matthew (Exec. VP Chief Legal Officer) has filed a Form 4 on TEVA PHARMACEUTICAL INDUSTRIES LTD
Txns:
| Sold 18,430 shares
@ $9.8866, valued at
$182.2k
Sold 44,953 shares
@ $9.8866, valued at
$444.4k
Exercised 18,430 options to buy
@ $0 Exercised 44,953 options to buy
@ $0 |
|
03/02/2023 |
4
| Shani Eli (EVP,Global Marketing&Portfolio) has filed a Form 4 on TEVA PHARMACEUTICAL INDUSTRIES LTD
Txns:
| Exercised 5,311 options to buy
@ $0 |
|
03/02/2023 |
4
| Sabag Mark (EVP, International Markets) has filed a Form 4 on TEVA PHARMACEUTICAL INDUSTRIES LTD
Txns:
| Exercised 20,598 options to buy
@ $0 Exercised 50,242 options to buy
@ $0 |
|
03/02/2023 |
4
| Kalif Eliyahu Sharon (EVP, CFO) has filed a Form 4 on TEVA PHARMACEUTICAL INDUSTRIES LTD
Txns:
| Exercised 18,430 options to buy
@ $0 Exercised 44,953 options to buy
@ $0 |
|
03/02/2023 |
4
| Inbar Galia (See "Remarks") has filed a Form 4 on TEVA PHARMACEUTICAL INDUSTRIES LTD
Txns:
| Exercised 4,828 options to buy
@ $0 |
|
03/02/2023 |
4
| Drape Eric (Executive VP Global Operations) has filed a Form 4 on TEVA PHARMACEUTICAL INDUSTRIES LTD
Txns:
| Sold 9,797 shares
@ $9.8866, valued at
$96.9k
Sold 23,888 shares
@ $9.8866, valued at
$236.2k
Exercised 19,514 options to buy
@ $0 Exercised 47,598 options to buy
@ $0 |
|
03/02/2023 |
4
| Dethlefs Sven (EVP, North America Commercial) has filed a Form 4 on TEVA PHARMACEUTICAL INDUSTRIES LTD
Txns:
| Sold 17,346 shares
@ $9.8866, valued at
$171.5k
Sold 42,309 shares
@ $9.8866, valued at
$418.3k
Exercised 17,346 options to buy
@ $0 Exercised 42,309 options to buy
@ $0 |
|
|
|
|